🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial employs a multicenter, randomized, open-label, standard-of-care-...
Status
Recruiting
Location
The Seventh Medical Center of Chinese PLA General Hospital
Start Date
2025-05-27
Trial ID
NCT06971094
Treatments Being Tested
SPINRAZA® (Nusinersen) is the first intrathecal administered drug which was...
Status
Active Not Recruiting
Location
CHU de Lyon
Start Date
2020-02-25
Trial ID
NCT04159987
Treatments Being Tested
With the advent of new treatments for ASI, new phenotypes are emerging. The...
Status
Recruiting
Location
Pediatric Rehabilitation Service - L'Escale Mother and Child Hospital
Start Date
2024-07-24
Trial ID
NCT06321965
In this study, researchers will learn more about the use of nusinersen (BII...
Status
Completed
Location
Arkansas Children's Hospital Research Institute
Start Date
2021-01-04
Trial ID
NCT04488133
Treatments Being Tested
The primary objective of the study is to examine the clinical efficacy of n...
Status
Terminated
Location
UCLA Medical Center
Start Date
2014-08-19
Trial ID
NCT02193074
Treatments Being Tested
The primary objective of the study is to examine the efficacy of multiple d...
Status
Completed
Location
David Geffen School of Medicine
Start Date
2015-05-18
Trial ID
NCT02386553
Treatments Being Tested
The primary objective is to examine the clinical efficacy of multiple doses...
Status
Completed
Location
Stanford University Medical Center
Start Date
2013-05-08
Trial ID
NCT01839656
Treatments Being Tested
The primary objective is to evaluate long-term safety and tolerability of n...
Status
Completed
Location
David Geffen School of Medicine at UCLA
Start Date
2015-11-04
Trial ID
NCT02594124
Treatments Being Tested
The primary objective of this study is to examine the safety and tolerabili...
Status
Completed
Location
Boston Children's Hospital
Start Date
2013-01-31
Trial ID
NCT01780246
Treatments Being Tested
In this study, researchers will learn more about the use of nusinersen (BII...
Status
Completed
Location
Stanford University Medical Center
Start Date
2021-04-19
Trial ID
NCT04729907
Treatments Being Tested